Hyderabad-based Hetero gets DCGI nod to manufacture, market Molnupiravir capsules
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read more
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreHyderabad: Hetero, one of India's leading generic pharmaceutical companies and the world's largest producer of antiretroviral drugs, on Wednesday announced ...
Read moreNew Delhi: Four domestic pharma firms – Cipla, Jubilant Life Sciences, Hetero and Mylan – have entered into non-exclusive licensing agreements ...
Read more
The Supreme Court ruling on 8 April declaring as erroneous and illegal the action of Tamil Nadu Governor RN Ravi,...
Read more
Of all the problems that India faces in its neighbourhood, the most pressing one seems to be emerging from Bangladesh...
Read more
One American – a poet (TS Eliot) – wrote many years ago, “April is the cruellest month.” Another American –...
Read more
How do trade wars end? To answer that, we have to ask ourselves, how do wars end? The answer is...
Read more
